ASPG and cancer: L-asparaginase, a key component of aLL chemotherapy, is thought to deplete asparagine from plasma, the major asparagine source for cancer cells, resulting in cellular asparagine deficit, inhibition of protein synthesis, and subsequent apoptosis [2].